Forbion

Investor type

VC

Founded

2006

AUM

$5 000 M

Location

Naarden, North Holland, Netherlands

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series B

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

Forbion is a leading global venture capital firm with deep expertise in Europe. We invest in innovative biotech companies, managing just over €5 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. In addition, we leverage our biotech expertise beyond human health to address ‘planetary health’ challenges through our BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies.

Industry

HealthTech MedTech Pharmaceuticals Medical Devices Financial Services Fintech Healthcare Services Biotechnology Robotics Life Sciences Food and Beverage Foodtech Fashion/Beauty SaaS Software Transportation Sports/SportsTech Energy

Region of investment

Europe

Forbion Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Forbion Growth Opportunities Fund I
Fund of funds
Food and Beverage
Foodtech
Healthcare Services
Robotics
HealthTech
Seed
Series A
Series B
North America
Europe
$5-10 m
$360 M
April 2021
Forbion Growth Opportunities Fund II
Fund of funds
Fashion/Beauty
Food and Beverage
Foodtech
Healthcare Services
Robotics
SaaS
Software
Transportation
HealthTech
Seed
Series A
Series B
North America
Europe
$5-10 m
$470 M
June 2022
Forbion Ventures Fund VI
Venture Capital (VC)
Fashion/Beauty
Food and Beverage
Foodtech
Robotics
SaaS
Sports/SportsTech
Energy
Pre-seed
Seed
North America
Europe
$5-10 m
$750 M
April 2023
Forbion Ventures Fund VII
Venture Capital (VC)
Fashion/Beauty
Food and Beverage
Foodtech
Healthcare Services
Robotics
Sports/SportsTech
Energy
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$890 M
October 2024

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
mLAgOEpQtbMNZzPf mLAgOEpQtbMNZzPf
mLAgOEpQtbMNZzPf
avatar
mLAgOEpQtbMNZzPf mLAgOEpQtbMNZzPf
mLAgOEpQtbMNZzPf
avatar
mLAgOEpQtbMNZzPf mLAgOEpQtbMNZzPf
mLAgOEpQtbMNZzPf
avatar
mLAgOEpQtbMNZzPf mLAgOEpQtbMNZzPf
mLAgOEpQtbMNZzPf
avatar
mLAgOEpQtbMNZzPf mLAgOEpQtbMNZzPf
mLAgOEpQtbMNZzPf
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Forbion

Forbion is located in Naarden, North Holland, Netherlands.
Forbion was founded in 2006.
Forbion invests in companies and startups in HealthTech, MedTech, Pharmaceuticals, Medical Devices, Financial Services, Fintech, Healthcare Services, Biotechnology, Robotics, Life Sciences, Food and Beverage, Foodtech, Fashion/Beauty, SaaS, Software, Transportation, Sports/SportsTech, Energy.
Forbion invests in companies and startups in Europe.
Forbion invests in companies and startups at Seed, Series B.
Forbion usually invests $10-50 m on average.
Forbion has around $5 000m assets under management.
Forbion last fund was created/launched in 2024-10-24